Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: KBr Pellet Method Optimization – V 2.0

Posted on By

Analytical Method Development: KBr Pellet Method Optimization – V 2.0

SOP for Optimization of KBr Pellet Method in FTIR Analysis


Department Analytical Method Development
SOP No. SOP/AMD/098/2025
Supersedes SOP/AMD/098/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the procedure for optimizing the potassium bromide (KBr) pellet technique used in FTIR spectroscopic analysis. Optimization ensures consistent pellet transparency, spectrum quality, and minimizes scattering artifacts in

fingerprint and functional group regions.

2. Scope

This SOP is applicable to all FTIR-based identity and fingerprint tests performed in the Analytical Method Development (AMD) laboratory using the KBr pellet method for APIs, intermediates, and excipients.

3. Responsibilities

  • Analytical Chemist: Prepares KBr pellets, performs spectrum acquisition, and evaluates pellet quality.
  • Method Reviewer: Assesses pellet consistency and verifies optimization logs.
  • QA Officer: Confirms compliance with GMP and regulatory expectations for spectral accuracy and reproducibility.
  • Head – AMD: Ensures approval of optimization data and authorizes use in validated procedures.

4. Accountability

The Head of Analytical Method Development is accountable for maintaining the consistency, reproducibility, and regulatory compliance of FTIR results derived using the KBr pellet method.

See also  Analytical Method Development: SOP for Documentation Review Before Report Finalization - V 2.0

5. Procedure

5.1 Reagents and Equipment

  1. Potassium Bromide (IR Grade): Use only spectroscopic-grade KBr, stored in a desiccator.
  2. Pellet Press: Hydraulic press with 10 mm die and polished stainless steel components.
  3. Mortar and Pestle: Agate or borosilicate for sample-KBr mixing.
  4. Desiccator: Silica-gel packed vacuum desiccator for pellet storage.

5.2 Drying of KBr and Samples

  1. Place sufficient quantity (~5 g) of KBr in a clean porcelain crucible.
  2. Dry at 105°C in a hot air oven for 2 hours.
  3. Cool in a desiccator for 30 minutes before use.
  4. For moisture-sensitive APIs, dry sample as per stability profile and document in Annexure-1: Drying Record.

5.3 Sample-to-KBr Ratio Optimization

  1. Weigh sample and KBr in different proportions:
    • Option 1: 1 mg sample + 100 mg KBr (1% w/w)
    • Option 2: 2 mg sample + 200 mg KBr (1% w/w)
    • Option 3: 2 mg sample + 100 mg KBr (2% w/w)
  2. Grind each mixture for 2–3 minutes in agate mortar until homogeneous and free-flowing.
  3. Press pellets under 10-ton pressure for 1–2 minutes using hydraulic press.
  4. Document pressure, ratio, and clarity outcome in Annexure-2: Optimization Matrix.
See also  Analytical Method Development: SOP for Ruggedness and Robustness Evaluation - V 2.0

5.4 Evaluation of Pellet Quality

  1. Pellet should be transparent and free from cracks or surface irregularities.
  2. Visually inspect clarity against white paper background.
  3. Poorly prepared pellets will scatter IR radiation and distort spectra.
  4. Log observations in Annexure-3: Pellet Clarity Evaluation Log.

5.5 FTIR Scanning and Spectrum Quality

  1. Collect background using blank KBr pellet before each scan.
  2. Scan the sample pellet using:
    • Range: 4000–400 cm-1
    • Resolution: 4 cm-1
    • Scans: 32–64
  3. Evaluate signal-to-noise ratio, peak sharpness, and fingerprint region clarity.
  4. Compare spectra from each pellet type to identify the most reproducible and high-quality spectrum.
  5. Record FTIR scan comparison in Annexure-4: Spectral Quality Comparison.

5.6 Finalization of Optimized Method

  1. Choose the sample-to-KBr ratio and compression conditions that yield:
    • High peak intensity
    • Clear baseline
    • Minimal spectral noise
  2. Fix this ratio as the standard for subsequent method development and validation.
  3. Document optimization summary in Annexure-5: Method Finalization Sheet.

6. Abbreviations

  • FTIR: Fourier Transform Infrared
  • KBr: Potassium Bromide
  • SOP: Standard Operating Procedure
  • API: Active Pharmaceutical Ingredient
  • w/w: Weight/Weight
  • cm-1: Wavenumber

7. Documents

  1. Drying Record – Annexure-1
  2. Optimization Matrix – Annexure-2
  3. Pellet Clarity Evaluation Log – Annexure-3
  4. Spectral Quality Comparison – Annexure-4
  5. Method Finalization Sheet – Annexure-5
See also  Analytical Method Development: SOP for Humidity-Induced Degradation Testing - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <197K> – Infrared Spectrophotometry
  • FTIR Instrument User Manual
  • Pharmaceutical Spectroscopy Reference Books

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Drying Record

Material Drying Temp (°C) Duration (min) Start Time End Time Remarks
KBr 105 120 10:00 12:00 Dried

Annexure-2: Optimization Matrix

Sample (mg) KBr (mg) Ratio (%) Pressure (tons) Pellet Status
1 100 1% 10 Clear
2 100 2% 10 Hazy

Annexure-3: Pellet Clarity Evaluation Log

Sample ID Visual Clarity Cracks Observed Acceptable (Y/N)
KBR-098-01 Transparent No Y

Annexure-4: Spectral Quality Comparison

Sample ID Signal-to-Noise Ratio Peak Shape Baseline Stability Conclusion
KBR-098-01 High Sharp Stable Best

Annexure-5: Method Finalization Sheet

Final Ratio (Sample:KBr) Pressure (tons) Scan Settings Approved By
1:100 10 4000–400 cm-1, 4 cm-1, 64 scans

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added annexures for pellet clarity and spectral quality evaluation Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: BA-BE Studies: SOP for Handling Bioanalytical Raw Data Files – V 2.0
Next Post: Creams: SOP for Testing Content Uniformity of Cream Products in Process – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version